Compounds, pharmaceutical compositions, kits and methods are provided for use with HDAC that comprise a compound selected from the group consisting of:
wherein the variables are as defined herein.
本发明提供了与H
DAC一起使用的化合物、药物组合物、试剂盒和方法,其中包括以下所述群组中选择的化合物:其中变量的定义如本文所述。